Article
Bone marrow angiotensin AT2 receptor deficiency aggravates atherosclerosis development by eliminating macrophage liver X receptor-mediated anti-atherogenic actions.
Journal of the renin-angiotensin-aldosterone system : JRAAS - 1 Dec 2015
Kato Taku, Kawahito Hiroyuki, Kishida Sou, Irie Daisuke, Wakana Noriyuki, Kikai Masakazu, Takata Hiroki, Ogata Takehiro, Ueyama Tomomi, Matoba Satoaki, Yamada Hiroyuki
Abstract excerpt
BACKGROUND: Bone marrow (BM) Angiotensin II (Ang II) type 1 (AT1) receptor plays a crucial role in atherosclerosis development; however, the effect of BM Ang II type 2 (AT2) receptor on atherogenesis remains undefined. METHODS AND RESULTS: We generated BM chimera apoE-deficient (apoE(-/-)) mice whose BM cells were repopulated with AT2-deficient (Agtr2(-/-)) or wild-type (Agtr2(+/+)) cells. After 2 months of a...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
